drugset / Trial / NCT02307396
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objective of the trial is to evaluate, how long an antipsychotic relapse-prevention should be continued and to which time a patient with schizophrenia is protected enough, so that a withdrawal or reduction of the medication seems appropriate. Relapse is defined as primary outcome.
Timeline
- Start
- 2015-02-01
- Primary completion
- 2016-06-22
- Completion
- 2016-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | — | — |
| Subject | Benperidol | Small molecule | — | — |
| Subject | Bromperidol | Small molecule | — | — |
| Subject | E-FLUPENTIXOL | Small molecule | — | — |
| Subject | Fluphenazine | Small molecule | — | — |
| Subject | Fluspirilene | Small molecule | — | — |
| Subject | Haloperidol | Other / unclassified | — | — |
| Subject | Olanzapine | Small molecule | — | — |
| Subject | Paliperidone | Unknown | — | — |
| Subject | Perazine | Small molecule | — | — |
| Subject | Perphenazine | Small molecule | — | — |
| Subject | Pimozide | Small molecule | — | — |
| Subject | Quetiapine | Small molecule | — | — |
| Subject | Risperidone | Other / unclassified | — | — |
| Subject | Sertindole | Small molecule | — | — |
| Subject | Sulpiride | Small molecule | — | — |
| Subject | Thioridazine | Unknown | — | — |
| Subject | Ziprasidone | Small molecule | — | — |
| Subject | Zuclopenthixol | Unknown | — | — |